The Clorox Company

NYSE:CLX USA Household & Personal Products
Market Cap
$13.47 Billion
Market Cap Rank
#1346 Global
#1024 in USA
Share Price
$111.40
Change (1 day)
-0.62%
52-Week Range
$97.43 - $148.69
All Time High
$209.55
About

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett… Read more

The Clorox Company (CLX) - Net Assets

Latest net assets as of December 2025: $35.00 Million USD

Based on the latest financial reports, The Clorox Company (CLX) has net assets worth $35.00 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.61 Billion) and total liabilities ($5.58 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $35.00 Million
% of Total Assets 0.62%
Annual Growth Rate -0.34%
5-Year Change -18.58%
10-Year Change 62.29%
Growth Volatility 78.43

The Clorox Company - Net Assets Trend (1986–2025)

This chart illustrates how The Clorox Company's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for The Clorox Company (1986–2025)

The table below shows the annual net assets of The Clorox Company from 1986 to 2025.

Year Net Assets Change
2025-06-30 $482.00 Million -2.03%
2024-06-30 $492.00 Million +26.80%
2023-06-30 $388.00 Million -46.78%
2022-06-30 $729.00 Million +23.14%
2021-06-30 $592.00 Million -34.80%
2020-06-30 $908.00 Million +62.43%
2019-06-30 $559.00 Million -23.00%
2018-06-30 $726.00 Million +33.95%
2017-06-30 $542.00 Million +82.49%
2016-06-30 $297.00 Million +151.69%
2015-06-30 $118.00 Million -23.38%
2014-06-30 $154.00 Million +5.48%
2013-06-30 $146.00 Million +208.15%
2012-06-30 $-135.00 Million -56.98%
2011-06-30 $-86.00 Million -203.61%
2010-06-30 $83.00 Million +147.43%
2009-06-30 $-175.00 Million +52.70%
2008-06-30 $-370.00 Million -316.37%
2007-06-30 $171.00 Million +209.62%
2006-06-30 $-156.00 Million +71.79%
2005-06-30 $-553.00 Million -135.91%
2004-06-30 $1.54 Billion +26.75%
2003-06-30 $1.22 Billion -10.27%
2002-06-30 $1.35 Billion -28.74%
2001-06-30 $1.90 Billion +5.91%
2000-06-30 $1.79 Billion +14.27%
1999-06-30 $1.57 Billion +44.67%
1998-06-30 $1.09 Billion +4.75%
1997-06-30 $1.04 Billion +11.06%
1996-06-30 $932.80 Million -1.18%
1995-06-30 $943.90 Million +3.79%
1994-06-30 $909.40 Million +3.42%
1993-06-30 $879.30 Million +8.06%
1992-06-30 $813.70 Million +3.75%
1991-06-30 $784.30 Million -3.23%
1990-06-30 $810.50 Million +3.09%
1989-06-30 $786.20 Million +10.28%
1988-06-30 $712.90 Million +15.66%
1987-06-30 $616.40 Million +12.11%
1986-06-30 $549.80 Million --

Equity Component Analysis

This analysis shows how different components contribute to The Clorox Company's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings $432.00 Million 134.58%
Common Stock $131.00 Million 40.81%
Other Comprehensive Income $-157.00 Million -48.91%
Total Equity $321.00 Million 100.00%

The Clorox Company Competitors by Market Cap

The table below lists competitors of The Clorox Company ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in The Clorox Company's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 328,000,000 to 321,000,000, a change of -7,000,000 (-2.1%).
  • Net income of 810,000,000 contributed positively to equity growth.
  • Dividend payments of 602,000,000 reduced retained earnings.
  • Share repurchases of 332,000,000 reduced equity.
  • Other comprehensive income decreased equity by 2,000,000.
  • Other factors increased equity by 119,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $810.00 Million +252.34%
Dividends Paid $602.00 Million -187.54%
Share Repurchases $332.00 Million -103.43%
Other Comprehensive Income $-2.00 Million -0.62%
Other Changes $119.00 Million +37.07%
Total Change $- -2.13%

Book Value vs Market Value Analysis

This analysis compares The Clorox Company's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 43.13x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1986-06-30 $2.58 $111.40 x
1987-06-30 $2.88 $111.40 x
1988-06-30 $3.30 $111.40 x
1989-06-30 $3.55 $111.40 x
1990-06-30 $3.75 $111.40 x
1991-06-30 $3.62 $111.40 x
1992-06-30 $3.73 $111.40 x
1993-06-30 $4.01 $111.40 x
1994-06-30 $4.23 $111.40 x
1995-06-30 $4.48 $111.40 x
1996-06-30 $4.51 $111.40 x
1997-06-30 $4.92 $111.40 x
1998-06-30 $5.23 $111.40 x
1999-06-30 $6.54 $111.40 x
2000-06-30 $7.49 $111.40 x
2001-06-30 $7.93 $111.40 x
2002-06-30 $5.77 $111.40 x
2003-06-30 $5.51 $111.40 x
2004-06-30 $7.18 $111.40 x
2005-06-30 $-3.09 $111.40 x
2006-06-30 $-1.02 $111.40 x
2007-06-30 $1.11 $111.40 x
2008-06-30 $-2.61 $111.40 x
2009-06-30 $-1.24 $111.40 x
2010-06-30 $0.59 $111.40 x
2011-06-30 $-0.62 $111.40 x
2012-06-30 $-1.02 $111.40 x
2013-06-30 $1.10 $111.40 x
2014-06-30 $1.17 $111.40 x
2015-06-30 $0.89 $111.40 x
2016-06-30 $2.25 $111.40 x
2017-06-30 $4.12 $111.40 x
2018-06-30 $5.52 $111.40 x
2019-06-30 $4.31 $111.40 x
2020-06-30 $7.11 $111.40 x
2021-06-30 $3.23 $111.40 x
2022-06-30 $4.49 $111.40 x
2023-06-30 $1.77 $111.40 x
2024-06-30 $2.63 $111.40 x
2025-06-30 $2.58 $111.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently The Clorox Company utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 252.34%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.40%
  • • Asset Turnover: 1.28x
  • • Equity Multiplier: 17.32x
  • Recent ROE (252.34%) is above the historical average (101.16%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1986 17.39% 8.78% 1.28x 1.54x $40.62 Million
1987 17.02% 9.32% 1.21x 1.51x $43.26 Million
1988 18.60% 10.52% 1.09x 1.62x $61.31 Million
1989 15.80% 9.16% 1.12x 1.54x $45.58 Million
1990 18.95% 10.35% 1.30x 1.40x $72.55 Million
1991 6.72% 3.20% 1.03x 2.04x $-25.73 Million
1992 12.13% 5.75% 1.06x 1.98x $17.33 Million
1993 18.99% 10.22% 0.99x 1.88x $79.07 Million
1994 23.32% 11.55% 1.08x 1.87x $121.16 Million
1995 21.27% 10.12% 1.04x 2.02x $106.41 Million
1996 23.81% 10.01% 1.02x 2.34x $128.82 Million
1997 28.96% 11.85% 0.91x 2.68x $196.40 Million
1998 31.61% 12.51% 0.90x 2.79x $234.48 Million
1999 15.67% 6.15% 0.97x 2.63x $89.00 Million
2000 21.96% 9.65% 0.94x 2.43x $214.60 Million
2001 17.00% 8.28% 0.98x 2.10x $133.00 Million
2002 23.78% 7.93% 1.12x 2.68x $186.60 Million
2003 40.58% 11.90% 1.13x 3.01x $371.50 Million
2004 35.65% 12.70% 1.13x 2.49x $395.00 Million
2005 0.00% 24.98% 1.21x 0.00x $1.15 Billion
2006 0.00% 9.56% 1.28x 0.00x $459.60 Million
2007 292.98% 10.34% 1.32x 21.44x $483.90 Million
2008 0.00% 8.74% 1.12x 0.00x $498.00 Million
2009 0.00% 9.85% 1.19x 0.00x $554.50 Million
2010 726.51% 11.52% 1.15x 54.88x $594.70 Million
2011 0.00% 10.65% 1.26x 0.00x $565.60 Million
2012 0.00% 9.89% 1.26x 0.00x $554.50 Million
2013 391.78% 10.17% 1.30x 29.53x $557.40 Million
2014 362.34% 10.12% 1.29x 27.65x $542.60 Million
2015 491.53% 10.26% 1.36x 35.29x $568.20 Million
2016 218.18% 11.25% 1.28x 15.21x $618.30 Million
2017 129.34% 11.74% 1.31x 8.44x $646.80 Million
2018 113.36% 13.44% 1.21x 6.97x $750.40 Million
2019 146.69% 13.20% 1.21x 9.15x $764.10 Million
2020 103.41% 13.97% 1.08x 6.84x $848.20 Million
2021 172.75% 9.67% 1.16x 15.41x $668.90 Million
2022 83.09% 6.50% 1.15x 11.08x $406.40 Million
2023 67.73% 2.02% 1.24x 27.02x $127.00 Million
2024 85.37% 3.95% 1.23x 17.53x $247.20 Million
2025 252.34% 11.40% 1.28x 17.32x $777.90 Million

Industry Comparison

This section compares The Clorox Company's net assets metrics with peer companies in the Household & Personal Products industry.

Industry Context

  • Industry: Household & Personal Products
  • Average net assets among peers: $1,833,853,398
  • Average return on equity (ROE) among peers: 27.58%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
The Clorox Company (CLX) $35.00 Million 17.39% 159.37x $13.42 Billion
Acme United Corporation (ACU) $19.90 Million 2.51% 0.55x $132.86 Million
Beiersdorf Aktiengesellschaft (BDRFF) $3.02 Billion 8.59% 0.75x $11.93 Billion
Science to Consumers Inc (BEUT) $-3.05K 0.00% 0.00x $1.09K
Société BIC SA (BICEY) $1.70 Billion 16.88% 0.41x $566.61 Million
Blue Moon Group Holdings Limited (BLUMY) $12.35 Billion 8.22% 0.18x $1.01 Billion
Bemax Inc (BMXC) $-244.86K 0.00% 0.00x $3.63K
Bruush Oral Care Inc. (BRSHF) $-216.93K 0.00% 0.00x $335.48
Park Ha Biological Technology Co., Ltd. (BYAH) $-578.18K 0.00% 0.00x $11.97 Million
Church & Dwight Company Inc (CHD) $284.43 Million 16.52% 2.34x $22.97 Billion
Colgate-Palmolive Company (CL) $971.00 Million 223.07% 14.49x $67.85 Billion